CAS Insights^TM

Advanced packaging and on-drug labeling are new technologies to fight counterfeit drugs

Metal-organic frameworks improve decarbonization technology, biomedicine and more, and AI makes them easier to use

Experts from CAS, Harvard Medical School, Procter & Gamble, and Cedars-Sinai Medical Center discuss health aging research.

PROTACs are driving small molecule drug development to treat cancer, neurodegenerative diseases and more

Discover how artificial intelligence in pharma can enhance drug repurposing by leveraging dark data, ensuring data diversity, and improving data quality.

The opportunities and challenges facing the development of goldene

Discover how CAS leverages advanced data management and predictive models to revolutionize drug discovery in this conversation with industry leaders.

While CAR-T cell therapy is mostly used for cancers, it has shown promising results in treating autoimmune diseases, HIV, and more

As solar panel usage increases, researchers are looking for new methods to tackle PV waste.

The GIP and GLP-1 function shows promising results in treating cardiovascular and neurodegenerative conditions.

Three categories of breakthroughs that have been awarded the Nobel Prize in Chemistry in the last forty years

Why are there no FDA approved TBK1 (TANK-binding kinase) inhibitors on the market, despite the key role it plays in the pathophysiology of many diseases.

Science and wearable tech go hand in hand to provide athletes with precise, personalized information to improve their performance.

With recent headlines on monkeypox, learn more about the research landscape, scientific profiles, and currently available therapies. A deeper understanding of the published science enables clarity and insight on this emerging news story.

Nanoscale drug delivery systems can improve treatment for cancer, autoimmune diseases, HIV, and other conditions

How QSAR modeling and machine learning identify potential new drug compounds for kinase inhibitors

Nanofibers, nanoplastics, and more are gaining research interest. See more nanotechnology breakthroughs through the lens of a CAS TrendScape analysis.

Rare diseases are difficult to treat, diagnose, and identify. As such, researchers are spending more effort in better understanding and treating these illnesses.

How combination therapies including drug repurposing, cell therapy, and genetic therapy are leading to improved treatment of rare diseases.

Combining advanced technologies with human curation identifies emerging trends in nanotechnology research.

How do science and sportswear fit together? Explore the innovations in fabrics and materials that are creating sportswear that help athletes boost their performance.

Dr. Zoheb Hassan, a senior consultant at Frost & Sullivan, shares his insights on the data management complexities that define the current drug discovery landscape.

Parkinson's disease can be distressing for families, so scientists are working hard to find potential treatments by repurposing drugs and more.

Uncover the latest advancements in understanding and treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s.

Recycling plastics can be challenging with traditional methods, leading to developments in chemical plastic recycling technology.